Investigator
Julie G Arenberg
MASSACHUSETTS EYE AND EAR INFIRMARY · funded by NIDCD
- Companies
- 3
- Grants
- 3
- Non-dilutive funding
- $1.8M
- First award
- Feb 1, 2012
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Sep 18, 2023.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- MASSACHUSETTS EYE AND EAR INFIRMARYMomentum in another area
NeuroGrant-only
- MASSACHUSETTS EYE AND EAR INFIRMARYMomentum in another area
NeuroGrant-only
- MASSACHUSETTS EYE AND EAR INFIRMARYMomentum in another area
NeuroGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R01
Improving Cochlear Implant Outcomes Through Modeling and Programming Strategies Based on Human Inner Ear Pathology
$601kSep 18, 2023NIDCDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11141859 (opens the source filing in a new tab)
- R01
Perceptual implications of cochlear implant electrode-neuron interfaces
$582kFeb 1, 2012NIDCDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11103277 (opens the source filing in a new tab)
- R01
Perceptual implications of cochlear implant electrode-neuron interfaces
$586kFeb 1, 2012NIDCDMASSACHUSETTS EYE AND EAR INFIRMARYNIH RePORTER · 11334269 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources